Anzeige
Mehr »
Donnerstag, 12.02.2026 - Börsentäglich über 12.000 News
Top-Ergebnisse: 1,75 g/t Gold über 30,4 Meter + massives Tagebau-Potenzial
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
23 Leser
Artikel bewerten:
(0)

MedCath Corporation, Benefis Agree To End Strategic Alliance


CHARLOTTE, N.C., Oct. 2 /PRNewswire-FirstCall/ -- MedCath Corporation and Benefis Healthcare of Great Falls, Mont., today announced their plans to end their strategic alliance. The alliance, announced in June 2005, was entered into with the intention of the two companies jointly working to evaluate the potential to expand and grow Benefis' cardiovascular services through an equity arrangement. The companies announced the alliance will terminate on or about Dec. 31.

"When we entered into this agreement more than a year ago, we both understood that this was a complex arrangement that had many moving parts. In the end, some of these caused both of us to conclude that converting the management agreement to an equity partnership did not fit either of our strategic ambitions," says Ed French, MedCath's president and chief executive officer. "We appreciate the leadership at Benefis for originally working with us to learn if we could structure something that might have involved an equity infusion. We have mutually agreed to not continue the exploration, and we do so on good terms."

"Strategically, we have determined that it is in our best interest to pursue our market objectives independently," says John Goodnow, President/CEO, Benefis Healthcare "We wish MedCath only the best as they pursue their development goals and strategies. Benefis remains as committed as ever to continuing to grow and develop our cardiovascular services to best meet the expanding needs of our communities."

Under the strategic alliance, MedCath has been managing Benefis' cardiovascular services and working with Benefis on the design and initial development stages of a new patient tower that will include four new floors dedicated entirely to comprehensive, state-of-the-art heart care. The original concept included an opportunity for MedCath to invest equity into the physical plant and operations.

Benefis Healthcare, one of the Northwest's leading healthcare providers, is a faith based, mission-driven, locally controlled and governed community/regional Health System, which includes the state's largest acute care hospital.

MedCath Corporation, headquartered in Charlotte, N.C., is a healthcare provider focused on the diagnosis and treatment of cardiovascular disease. MedCath focuses on serving the unique needs of patients suffering from cardiovascular disease. MedCath currently owns interests in and operates eleven hospitals with a total of 667 licensed beds, located in Arizona, Arkansas, California, Louisiana, New Mexico, Ohio, South Dakota, and Texas. In addition to its hospitals, MedCath provides cardiovascular care services in diagnostic and therapeutic facilities located in various states.
© 2006 PR Newswire
Favoritenwechsel
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.